Smart Trade Insights
  • Business
  • Economy
  • Investing
  • Politics
Top Posts
China Grants Conditional Approval to Codelco-SQM Lithium Joint...
Trump’s Fed Feud: Fears Over Fed Independence Benefit...
Drilling Commenced for Sybella-Barkly Uranium and Rare Earth
Mine life extensions indicated with Laverton drilling
ReeXploration
ReeXploration: Building the Next Generation of Responsible Critical...
Omar Ayales: Is Gold’s Run Over? Signals I’m...
Jordan Roy-Byrne: Gold, Silver Going Much Higher, “Powerful...
US Reinstates Uranium as Critical Mineral, Boosting Domestic...
AI, Energy Transition and COP30 Present New Opportunities...
  • Business
  • Economy
  • Investing
  • Politics

Smart Trade Insights

Economy

Top Stock Gainers And Losers: IBRX +26.37%, CPRI -48.89%

by admin October 29, 2024
October 29, 2024
Top Stock Gainers And Losers: IBRX +26.37%, CPRI -48.89%

Top Gainers

Symbol Company Name Price Change Change %
IBRX ImmunityBio, Inc.  5.32 +1.11 +26.37%
Zk ZEEKR Intelligent Technology Holding Limited 28.85 +5.74 +24.84%
NWL Newell Brands Inc. 8.73 +1.55 +21.59%
TPR Tapestry, Inc.  50.49 +6.02 +13.54%
DJT Trump Media & Technology Group Corp. 38.95 +4 +11.44%

Top Losers

Symbol Company Name Price Change Change %
CPRI Capri Holdings Limited  21.26 -20.34 -48.89%
JOBY Joby Aviation, Inc.  5.16 -0.88 -14.57%
TBBK The Bancorp, Inc.  47.01 -7.95 -14.47%
MHK Mohawk Industries, Inc.  130.88 -20.99 -13.82
CRI Carter’s Inc. 56.95 -8.74 -13.30%

 

After a sideways opening market tried holding on to higher levels, but as of the last few trading sessions, selling continued in the market after an hour or two.  

  • NYSE Composite: -104.4 (-0.53%)
  • Dow Jones: -259.96 (-0.61%)
  • S&P 500: -1.76 (+0.03%)

#1 Gainer: IBRX Stock

ImmunityBio Inc. (NASDAQ: IBRX) stock turned out to be the top gainer after delivering nearly +77% returns in a single day and, by the end of the day, closing at +26.37%. 

ImmunityBio Inc. rallied for two consecutive days as the company announced the initiation of doses in phase 1 for CD19 t-haNK cell therapy. The trial has been named QUILT 106. This testing will be done on 100 patients looking for a cure in natural killer cell-based cellular therapy like non-Hodgkin lymphoma, a cancer of the lymphatic system. This trial is being conducted in Johannesburg, Pretoria and Bloemfontein. 

The investors are keeping high hopes with the upcoming results of the trial, as this can be a game changer for both company and market movers. 

IBRX Stock 15-Minute Chart

The stock broke all the above resistance after delivering staggering returns of +26.37 in a single day. Making an entry due to FOMO can result in risking huge amounts of money. Looking into the technicals on the 1-day time frame. We can clearly see the stock was selling for a long time.

Before giving a breakout, the price was in the channel, as marked in the image. Buyers were taking a position in the sock. Looking at the current situation, the market made an inverted pin bar like a candle which indicates heavy selling from higher levels. 

You can enter if the price retests the $3.95 level. Place your stop loss at $2.90 and set targets at $6.77 and $7.63.

#1 Loser: CPRI Stock

Capri Holdings Limited (NASDAQ: CPRI) stock faced a -48.89% decline in just one single day, wiping out $2.2 billion from the market cap. 

The stock tumbled after a judge blocked the $8.5 billion tapestry deal, making it difficult for the company to sustain in luxury brand competition. This deal was proposed last year to compete with European giants by bringing major brands under one roof. 

Due to inflation and current market conditions, luxury brands face challenges due to customers focusing on essential buying. This makes it hard for the company to sustain itself. 

Capri could plan to seek another suitor, said Dana Telsey of Telsey Advisory Group, but with the delay in the deal and weak results, investors are looking for their trust in the stock. 

CPRI/USD 15-Minute Chart

After facing a huge selling of -48.89%, the market is in a selling trend on a weekly time frame. RSI is near 30 levels, indicating selling pressure is still ongoing. 

The selling position could trigger if the price breaks the previous day’s low ($20.99) with a target of $8.38 and a stop-loss of $31.69. 

The post Top Stock Gainers And Losers: IBRX +26.37%, CPRI -48.89% appeared first on FinanceBrokerage.

previous post
Nvidia overtakes Apple as world’s most valuable company
next post
S&P 500 and Nasdaq: Prices and Targets for Friday

You may also like

S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped...

December 5, 2024

The S&P 500 and Nasdaq retreated to new...

October 3, 2024

S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped...

December 17, 2024

Stock Futures Lower after S&P 500 futures ticked...

December 5, 2024

Nvidia Stock Hits Record High of $146.47

November 9, 2024

Bitcoin loses bullish momentum on Monday and drops...

October 9, 2024

Nvidia hit a $4 trillion market valuation

November 21, 2024

S&P 500 climbed 0.3%, and Nasdaq-100 futures jumped...

December 20, 2024

Ripple and Tron: Targets and support levels for...

October 25, 2024

Top Crypto Gainers & Losers: SANTOS Token +57%,...

October 31, 2024

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • China Grants Conditional Approval to Codelco-SQM Lithium Joint Venture

      November 12, 2025
    • Trump’s Fed Feud: Fears Over Fed Independence Benefit Gold

      November 12, 2025
    • Drilling Commenced for Sybella-Barkly Uranium and Rare Earth

      November 12, 2025
    • Mine life extensions indicated with Laverton drilling

      November 12, 2025
    • ReeXploration

      November 12, 2025
    Promotion Image

    banner ads

    Categories

    • Business (901)
    • Economy (829)
    • Investing (3,227)
    • Politics (737)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smarttradeinsights.com | All Rights Reserved